Combining drug and gene similarity metrics for drug-target elucidation
(L. Perlman, A. Gottlieb, N. Atias, E. Ruppin, R. Sharan)
Journal of Computational Biology (JCB), to appear.
A novel HMM-based method for detecting enriched transcription
factor binding sites reveals RUNX3 as a potential target in pancreatic
cancer biology
(L. Levkovitz, N. Yosef, M.C. Gershgoren, E. Ruppin, R. Sharan, Y. Oron)
PLoS One, to appear.